“life-sciences” Archives

in
Entry Author Date Location
A Year After CEO’s Departure, Quintessence Remains ‘Dormant’ 01/06/17 Wisconsin
PatientsLikeMe Nabs $100M, Works to Advance Personalized Medicine 01/06/17 Boston
Scangos Surfaces to Lead New Infectious Disease Startup, Vir Biotech 01/06/17 San Francisco
Foundation, Roche Deepen Ties as Genentech Vet Steps in for CEO Pellini 01/06/17 Boston
Bio Roundup: Biogen Price Fears, A Grail Billion, Hellos, Byes & More 01/06/17 National
Families Fret As Insurers Mull Biogen’s $750K Spine Disease Drug 01/06/17 National
Biopharma Industry, Heal Thyself (Without Government Help) 01/06/17 San Diego
Grail Raising $1 Billion To Fund Trials For Cancer DNA Test 01/05/17 San Diego
Cancer Diagnostic Startup Capio Moves to Wisconsin, Raises $2.9M 01/05/17 Wisconsin
Frequency, Led by MIT’s Langer, Aims to Fight Hearing Loss With Drugs 01/05/17 Boston
PvP Biologics Raises $35M in a Lab-to-Pharma Deal with Takeda 01/05/17 San Diego
Neon Therapeutics Hauls in $70M for Personalized Cancer Vaccines 01/05/17 Boston
HLI Adds Cynthia Collins as CEO, Venter Moves to Executive Chairman 01/04/17 San Diego
Infinity Pharma R&D Chief Adams Retires Amid Restructuring, Job Cuts 01/04/17 Boston
Edico Genome’s Deal with Dell EMC Fits Partnership Strategy 01/04/17 San Diego
Digitalis Launches $100M Health Fund, With Emphasis On Data 01/04/17 New York
RaNA Expands, Joins Messenger RNA Drug Race With Shire Deal 01/04/17 Boston
Versant Closes on $400M Fund, Eyes More Biotech Deals in Europe 01/03/17 San Francisco
Inotek’s Glaucoma Drug Flunks in First Phase 3 Test, Shares Crumble 01/03/17 Boston
First Trial Underway, Jounce Preps IPO To Fund Immuno-Oncology Work 01/03/17 Boston
Watching for NIH Innovation in 2017—and Drug Pricing, Trade Deals 01/02/17 San Diego
Varmus, Sato on Steering De Blasio’s $500M Plan to Grow NY Biotech 12/30/16 New York
Gates Foundation Sends $140M to Intarcia for HIV Version of Pump 12/29/16 Boston
Cellular Dynamics Plans to Relocate, Build New Manufacturing Center 12/29/16 Wisconsin
FDA Rejects Cempra Antibiotic, Asks for Another Clinical Trial 12/29/16 Raleigh Durham
Biogen Sets $750,000 Initial Price For First-Ever Spinal Atrophy Drug 12/28/16 Boston
Anthera’s Shares Tumble After Cystic Fibrosis Drug Fails in Phase 3 12/28/16 San Francisco
Diabetes Study, Hiring News, Growth Mileposts, & More Local Tech News 12/27/16 Indiana
Liver Damage, Patient Deaths Lead FDA to Halt SeaGen Leukemia Trials 12/27/16 Seattle
Ionis, Biogen Make History With FDA Nod for Spine Disease Drug 12/23/16 Boston
Page 2 of 313 « previous page · next page »